GENPF (Genix Pharmaceuticals) Interest Expense: $-0.13 Mil (TTM As of Apr. 2026)


What is Genix Pharmaceuticals Interest Expense?

Genix Pharmaceuticals GENPF Interest Expense is $-0.13 Mil as of Apr. 2026. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Genix Pharmaceuticals's interest expense for the three months ended in Apr. 2026 was $ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.13 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Genix Pharmaceuticals's Operating Income for the three months ended in Apr. 2026 was $ -0.02 Mil. Genix Pharmaceuticals's Interest Expense for the three months ended in Apr. 2026 was $ -0.04 Mil. Genix Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Genix Pharmaceuticals  (OTCPK:GENPF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Genix Pharmaceuticals's Interest Expense for the three months ended in Apr. 2026 was $-0.04 Mil. Its Operating Income for the three months ended in Apr. 2026 was $-0.02 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Apr. 2026 was $0.00 Mil.

Genix Pharmaceuticals's Interest Coverage for the quarter that ended in Apr. 2026 is calculated as

Genix Pharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Genix Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Genix Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals Interest Expense Chart

Genix Pharmaceuticals Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.01 -0.04 -0.09 -0.12

Genix Pharmaceuticals Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.03 -0.04 -0.03 -0.04

Genix Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.13 Mil mean?
Genix Pharmaceuticals (GENPF) has a Interest Expense of $-0.13 Mil as of Apr. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Genix Pharmaceuticals and its competitors.
Is Genix Pharmaceuticals' Interest Expense too high?
Genix Pharmaceuticals' current Interest Expense is $-0.13 Mil.
How does Genix Pharmaceuticals' Interest Expense compare to ZTS and UTHR?
Genix Pharmaceuticals' Interest Expense of $-0.13 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Genix Pharmaceuticals and its competitors. Genix Pharmaceuticals's current Interest Expense is $-0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current Interest Expense of $-0.13 Mil. The current Interest Expense is $-0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current Interest Expense is $-0.13 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genix Pharmaceuticals Business Description

Other Exchanges GENX:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.